AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
5.20
+0.06 (1.17%)
At close: Jun 26, 2026, 4:00 PM EDT
5.20
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $187.28 million as of June 26, 2026. Its market cap has increased by 444.43% in one year.
Market Cap
187.28M
Enterprise Value
102.00M
1-Year Change
444.43%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $187.28M, a decrease of -33.37%. That is a compound annual growth rate of -9.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 187.28M | 499.53% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 194.59M |
| Arcturus Therapeutics Holdings | 193.85M |
| Minerva Neurosciences | 191.48M |
| Compugen | 191.06M |
| Tonix Pharmaceuticals Holding | 190.97M |
| MediWound | 187.51M |
| Canton Strategic Holdings | 187.43M |
| Equillium | 186.52M |